Indian students and professionals chasing the glitzy American Dream may have to think twice now, as it comes with a cost: visa insecurity. The Secretariat decodes the US visa labyrinth

The Indian pharma industry is still not in panic mode despite Trump's move. Decision to slap 100% tariff on pharma products -- both branded and patented -- may run into political constraints, forcing a potential rollback

A proactive approach is being made to explore markets and investment opportunities to ensure exporters have diverse options at a time of global economic uncertainty